Published in Inflamm Bowel Dis on February 01, 2005
A Trial of Yoga in Pediatric Inflammatory Bowel Disease | NCT03338894
A meta-analytic review of the psychosocial adjustment of youth with inflammatory bowel disease. J Pediatr Psychol (2010) 1.30
Psychosocial issues in pediatric inflammatory bowel disease: report of the North American Society for Pediatric Gastroenterology, Hepatology, and Nutrition. J Pediatr Gastroenterol Nutr (2013) 1.19
Special issues in pediatric inflammatory bowel disease. World J Gastroenterol (2008) 1.11
Health supervision in the management of children and adolescents with IBD: NASPGHAN recommendations. J Pediatr Gastroenterol Nutr (2012) 1.10
Challenges and strategies of children and adolescents with inflammatory bowel disease: a qualitative examination. Health Qual Life Outcomes (2007) 1.01
Health-related quality of life changes of children and adolescents with chronic disease after participation in therapeutic recreation camping program. Health Qual Life Outcomes (2011) 0.87
Telephone Consultation as a Substitute for Routine Out-patient Face-to-face Consultation for Children With Inflammatory Bowel Disease: Randomised Controlled Trial and Economic Evaluation. EBioMedicine (2015) 0.86
Disease knowledge after an educational program in patients with GERD--a randomized controlled trial. BMC Health Serv Res (2008) 0.83
Effective peer-to-peer support for young people with end-stage renal disease: a mixed methods evaluation of Camp COOL. BMC Nephrol (2013) 0.78
Self-management in patients with inflammatory bowel disease: strategies, outcomes, and integration into clinical care. Clin Exp Gastroenterol (2016) 0.77
Pediatric inflammatory bowel disease and depression: treatment implications. Curr Opin Pediatr (2014) 0.76
Impact of gluten-free camp on quality of life of children and adolescents with celiac disease. Pediatrics (2010) 0.75
Medical students' conceptualizations of quality of life associated with children with IBD. J Pediatr Gastroenterol Nutr (2013) 0.75
Human gut microbiome viewed across age and geography. Nature (2012) 19.31
Genome-wide meta-analysis increases to 71 the number of confirmed Crohn's disease susceptibility loci. Nat Genet (2010) 17.38
Eosinophilic esophagitis: updated consensus recommendations for children and adults. J Allergy Clin Immunol (2011) 12.48
Meta-analysis identifies 29 additional ulcerative colitis risk loci, increasing the number of confirmed associations to 47. Nat Genet (2011) 7.98
Common variants at five new loci associated with early-onset inflammatory bowel disease. Nat Genet (2009) 3.82
Loci on 20q13 and 21q22 are associated with pediatric-onset inflammatory bowel disease. Nat Genet (2008) 3.36
Eosinophilic esophagitis: a 10-year experience in 381 children. Clin Gastroenterol Hepatol (2005) 3.34
Development, validation, and evaluation of a pediatric ulcerative colitis activity index: a prospective multicenter study. Gastroenterology (2007) 2.96
Safety and steroid-sparing experience using infliximab for Crohn's disease at a pediatric inflammatory bowel disease center. Am J Gastroenterol (2003) 2.58
Pediatric Crohn disease patients exhibit specific ileal transcriptome and microbiome signature. J Clin Invest (2014) 2.39
Effect of a probiotic preparation (VSL#3) on induction and maintenance of remission in children with ulcerative colitis. Am J Gastroenterol (2009) 2.34
Risk factors for initial surgery in pediatric patients with Crohn's disease. Gastroenterology (2006) 2.22
Safety of intravenous midazolam and fentanyl for pediatric GI endoscopy: prospective study of 1578 endoscopies. Gastrointest Endosc (2007) 2.22
Longitudinal assessment of bone density and structure in an incident cohort of children with Crohn's disease. Gastroenterology (2008) 2.21
Challenges in meeting fellowship procedural guidelines in pediatric therapeutic endoscopy and liver biopsy. J Pediatr Gastroenterol Nutr (2014) 2.12
Development of the gastrointestinal endoscopy competency assessment tool for pediatric colonoscopy (GiECAT KIDS). J Pediatr Gastroenterol Nutr (2014) 2.06
Endoscopic mucosal resection and endoscopic submucosal dissection. Gastrointest Endosc (2008) 1.95
Overtube use in gastrointestinal endoscopy. Gastrointest Endosc (2009) 1.94
Reslizumab in children and adolescents with eosinophilic esophagitis: results of a double-blind, randomized, placebo-controlled trial. J Allergy Clin Immunol (2011) 1.82
Management of ingested magnets in children. J Pediatr Gastroenterol Nutr (2012) 1.78
Differentiating ulcerative colitis from Crohn disease in children and young adults: report of a working group of the North American Society for Pediatric Gastroenterology, Hepatology, and Nutrition and the Crohn's and Colitis Foundation of America. J Pediatr Gastroenterol Nutr (2007) 1.74
Narrow band imaging and multiband imaging. Gastrointest Endosc (2008) 1.65
Immune response to influenza vaccine in pediatric patients with inflammatory bowel disease. Clin Gastroenterol Hepatol (2007) 1.64
Medication adherence and quality of life in pediatric inflammatory bowel disease. J Pediatr Psychol (2008) 1.60
Objective versus subjective assessment of oral medication adherence in pediatric inflammatory bowel disease. Inflamm Bowel Dis (2009) 1.59
Growth hormone treatment for growth failure in pediatric patients with Crohn's disease. J Pediatr (2008) 1.58
Minimizing occupational hazards in endoscopy: personal protective equipment, radiation safety, and ergonomics. Gastrointest Endosc (2010) 1.57
Infliximab in pediatric ulcerative colitis: two-year follow-up. J Pediatr Gastroenterol Nutr (2004) 1.55
A randomized, double-blind trial of Lactobacillus GG versus placebo in addition to standard maintenance therapy for children with Crohn's disease. Inflamm Bowel Dis (2005) 1.55
The gastrointestinal endoscopy competency assessment tool for pediatric colonoscopy. J Pediatr Gastroenterol Nutr (2015) 1.52
Polyethylene glycol powder solution versus senna for bowel preparation for colonoscopy in children. J Pediatr Gastroenterol Nutr (2013) 1.49
Predictors of immunomodulator use as early therapy in pediatric Crohn's disease. J Clin Gastroenterol (2006) 1.41
Frostbite of the esophagus. J Pediatr Gastroenterol Nutr (2007) 1.39
Magnet ingestion in children. J Pediatr Gastroenterol Nutr (2013) 1.39
Hepatosplenic T-cell lymphoma in adolescents and young adults with Crohn's disease: a cautionary tale? Inflamm Bowel Dis (2007) 1.37
Severe pediatric ulcerative colitis: a prospective multicenter study of outcomes and predictors of response. Gastroenterology (2010) 1.32
Inflammatory bowel disease in children 5 years of age and younger. Am J Gastroenterol (2002) 1.32
Characterization of Notch receptor expression in the developing mammalian heart and liver. Am J Med Genet (2002) 1.32
Large sample size, wide variant spectrum, and advanced machine-learning technique boost risk prediction for inflammatory bowel disease. Am J Hum Genet (2013) 1.31
Variation in care in pediatric Crohn disease. J Pediatr Gastroenterol Nutr (2009) 1.26
Determinants of changes in linear growth and body composition in incident pediatric Crohn's disease. Gastroenterology (2010) 1.26
Patient and parent psychosocial factors associated with health-related quality of life in pediatric inflammatory bowel disease. J Pediatr Gastroenterol Nutr (2011) 1.25
Gender differences in body composition deficits at diagnosis in children and adolescents with Crohn's disease. Inflamm Bowel Dis (2007) 1.23
Disease activity, behavioral dysfunction, and health-related quality of life in adolescents with inflammatory bowel disease. Inflamm Bowel Dis (2010) 1.23
Inflammatory bowel disease: the difference between children and adults. Inflamm Bowel Dis (2008) 1.22
Development of extraintestinal manifestations in pediatric patients with inflammatory bowel disease. Inflamm Bowel Dis (2009) 1.21
Management of ingested foreign bodies in children: a clinical report of the NASPGHAN Endoscopy Committee. J Pediatr Gastroenterol Nutr (2015) 1.21
Presentation and disease course in early- compared to later-onset pediatric Crohn's disease. Am J Gastroenterol (2008) 1.19
Appraisal of the pediatric ulcerative colitis activity index (PUCAI). Inflamm Bowel Dis (2009) 1.18
Gender differences in presentation and course of disease in pediatric patients with Crohn disease. Pediatrics (2007) 1.18
Is an abbreviated Pediatric Crohn's Disease Activity Index better than the original? J Pediatr Gastroenterol Nutr (2004) 1.16
Capsule endoscopy of the colon. Gastrointest Endosc (2008) 1.16
Consensus for managing acute severe ulcerative colitis in children: a systematic review and joint statement from ECCO, ESPGHAN, and the Porto IBD Working Group of ESPGHAN. Am J Gastroenterol (2011) 1.16
Incidence of stricturing and penetrating complications of Crohn's disease diagnosed in pediatric patients. Inflamm Bowel Dis (2010) 1.14
Long-term outcome of maintenance infliximab therapy in children with Crohn's disease. Inflamm Bowel Dis (2009) 1.13
Human antichimeric antibody in children and young adults with inflammatory bowel disease receiving infliximab. J Pediatr Gastroenterol Nutr (2004) 1.11
Inflammatory bowel disease in early childhood and adolescence: special considerations. Gastroenterol Clin North Am (2003) 1.08
Association of the T300A non-synonymous variant of the ATG16L1 gene with susceptibility to paediatric Crohn's disease. Gut (2007) 1.08
Ultrathin endoscopes. Gastrointest Endosc (2010) 1.08
Endoscopic tattooing. Gastrointest Endosc (2010) 1.07
Safety and efficacy of adalimumab for moderate to severe Crohn's disease in children. Gastroenterology (2012) 1.07
Retrospective Evaluation of the Safety and Effect of Adalimumab Therapy (RESEAT) in pediatric Crohn's disease. Am J Gastroenterol (2009) 1.07
A role for food allergy testing in eosinophilic esophagitis. J Allergy Clin Immunol (2012) 1.07
Barriers to oral medication adherence for adolescents with inflammatory bowel disease. J Pediatr Psychol (2009) 1.07
Use of 6-mercaptopurine/azathioprine as the immunomodulator of choice for moderately active Crohn's disease: balance. Inflamm Bowel Dis (2005) 1.06
Treatment adherence in adolescents with inflammatory bowel disease: the collective impact of barriers to adherence and anxiety/depressive symptoms. J Pediatr Psychol (2011) 1.06
Endoscopic hemostatic devices. Gastrointest Endosc (2009) 1.05
Inflammatory bowel disease in African American children compared with other racial/ethnic groups in a multicenter registry. Clin Gastroenterol Hepatol (2008) 1.03
Hepatosplenic T-cell lymphoma in an adolescent patient after immunomodulator and biologic therapy for Crohn disease. J Pediatr Gastroenterol Nutr (2005) 1.03
Total dose intravenous infusion of iron dextran for iron-deficiency anemia in children with inflammatory bowel disease. J Pediatr Gastroenterol Nutr (2002) 1.03
Measuring quality of life in pediatric patients with inflammatory bowel disease: psychometric and clinical characteristics. J Pediatr Gastroenterol Nutr (2008) 1.02
Colonoscopy preparation. Gastrointest Endosc (2009) 1.01
Patterns of complementary and alternative medicine use in a population of pediatric patients with inflammatory bowel disease. Inflamm Bowel Dis (2004) 1.00
Factors that determine risk for surgery in pediatric patients with Crohn's disease. Clin Gastroenterol Hepatol (2010) 1.00
Comparative Effectiveness of Nutritional and Biological Therapy in North American Children with Active Crohn's Disease. Inflamm Bowel Dis (2015) 0.99
Phase I trial of sargramostim in pediatric Crohn's disease. Inflamm Bowel Dis (2010) 0.97
Course and treatment of perianal disease in children newly diagnosed with Crohn's disease. Inflamm Bowel Dis (2009) 0.97
Biliary and pancreatic stone extraction devices. Gastrointest Endosc (2009) 0.96